Uroporphyria induced by 5-aminolaevulinic acid alone in Ahr(d) SWR mice

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1407-1413

  Constantin, Despina ^a   Francis, Jean E ^a   Akhtar, Ruth A ^a   Clothier, Bruce ^a   Smith, Andrew G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

5 aminolaevulinic acid; genetic variation; mice; uroporphyria

Indexed keywords

AMINOLEVULINIC ACID; AROMATIC HYDROCARBON RECEPTOR; COPROPORPHYRIN; CYTOCHROME P450 ISOENZYME; HEXACHLOROBENZENE; IRON DEXTRAN; PHENOBARBITAL; PORPHYRIN; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; GENETIC VARIABILITY; INTRAPERITONEAL DRUG ADMINISTRATION; IRON OVERLOAD; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINOLEVULINIC ACID; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; IRON OVERLOAD; LIVER; MALE; MICE; MICE, INBRED DBA; PORPHYRIAS; RECEPTORS, ARYL HYDROCARBON; SPECIES SPECIFICITY; UROPORPHYRINOGEN DECARBOXYLASE;

EID: 0030575938     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00475-3     Document Type: Article

References (39)

1. 1. Kappas A, Sassa S, Galbraith RA and Nordmann Y, The porphyrias. In: The Metabolic and Molecular Basis of Inherited Disease. 7th ed. (Eds. Scriver CR, Benaudet AL, Sly WS and Valle D), pp. 2103-2159. McGraw-Hill, New York, 1995.
2. 2. Elder GH, Urquhart AJ, De Salamanca RE, Munoz JJ and Bonkovsky HL, Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1:229-233, 1985.
3. 3. Kushner JP, Edwards CQ, Dadone MM and Skolnick MH, Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology 88: 1232-1238, 1985.
4. 4. Edwards CQ, Griffen LM, Goldgar DE, Skolnick MH and Kushner JP, HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 97: 972-982, 1989.
5. 5. Elder GH and Roberts AG, Uroporphyrinogen decarboxylase. J Bioenerg Biomem 27: 207-214, 1995.
6. 6. Jones KG and Sweeney GD, Dependence of the porphyrinogenic effect of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness. Toxicol Appl Pharmacol 53: 42-49, 1980.
7. 7. Smith AG and Francis JE, Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice. Biochem J 214: 909-913, 1983.
8. b-3 alleles. Molec Pharmacol 38: 306-312, 1990.
9. 9. Smith AG and De Matte is F, Oxidative injury mediated by the hepatic cytochrome P450 system in conjunction with cellular iron. Xenobiotica 20: 865-877, 1990.
10. 10. Smith AG and Francis JE, Genetic variation of iron-induced porphyria in mice. Biochem J 291: 29-35, 1993.
11. 11. Jones KG, Cole FM and Sweeney GD, The role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD). Toxicol Appl Pharmacol 61: 74-88, 1981.
12. 12. Greig JB, Francis JE, Kay SJE, Lovell DP and Smith AG, Incomplete correlation in 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice. Toxicol Appl Pharmacol 74: 17-25, 1984.
13. 13. Deam S and Elder GH, Uroporphyria produced in mice by iron and 5-aminolevulinic acid. Biochem Pharmacol 41: 2019-2022, 1991.
14. 14. Urquhart AJ, Elder GH, Roberts AG, Lambrecht RW, Sinclair PR, Bernent WJ, Gorman N and Sinclair JA, Uroporphyia produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid. Biochem J 253: 357-362, 1988.
15. 15. Sinclair P, Bernent WJ, Lambrecht RW, Jacobs JM and Sinclair JF, Uroporphyria caused by acetone and 5-aminolevulinic acid in iron-loaded mice. Biochem Pharmacol 38: 4341-4344, 1989.
16. 16. Granick S, Sinclair P, Sassa S and Grieninger G, Effects of heme, insulin and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem 250: 9215-9225, 1975.
17. 17. Grandchamp B, Deybach JC, Grelier M, de Verneuil H and Nordmann Y, Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria. Biochem Biophys Acta 629: 577-586, 1980.
18. 18. Francis JE and Smith AG, Assay of mouse liver uroporphyrinogen decarboxylase by reverse-phase high-performance liquid chromatography. Anal Biochem 138: 404-410, 1984.
19. 19. Carthew P, Dorman BM, Edwards RE, Francis JE and Smith AG, A unique rodent model for the both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 69: 217-222, 1993.
20. 20. Smith AG, Francis JE, Green JA, Greig JB, Wolf CR and Manson MM, Sex-linked hepatic uroporphyria and the induction of cytochromes P4501A in rats caused by hexachlorobenzene and polyhalogenated biphenyls. Biochem Pharmacol 40: 2059-2068, 1990.
21. 21. Madra S and Smith AG, Induction of cytochrome P450 activities by polychlorinated biphenyls in isolated mouse hepatocytes. Biochem Pharmacol 44: 455-464, 1992.
22. 22. Brady AM and Lock EA, Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals. Arch Toxicol 66: 175-181, 1992.
23. 23. Schmidt JV, Carver LA and Bradfield CA, Molecular characterization of the murine Ahr gene. Organization, promoter analysis, and chromosomal assignment. J Biol Chem 268: 2203-2209, 1993.
24. 24. Sinclair PR, Bernent WJ, Lambrecht RW, Gorman N and Sinclair JF, Chlorinated biphenyls induce cytochrome P4501A2 and uroporphyrin accumulation in cultures of mouse hepatocytes. Arch Biochem Biophys 281: 1-8, 1990.
25. 25. Smith AG and Francis JE, Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload. Biochem J 246: 221-226, 1987.
26. 26. Lambrecht RW, Sinclair PR, Gorman N and Sinclair JF, Uroporphyrinogen oxidation catalysed by reconstituted cytochrome P4501A2. Arch Biochem Biophys 294: 504-510, 1992.
27. 27. Nerurkar PV, Park SS, Thomas PE, Nims RW and Lubet RA, Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46: 933-943, 1993.
28. 28. Francis JE and Smith AG, Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations. Biochem Biophy Res Commun 146: 13-20, 1987.
29. 29. Greig JB, Francis JE and Smith AG, Genetic control of the hepatotoxicity of 2,3,7,8-tetrachlordibenzo-p-dioxin in mice. In: Organohalogen Compounds Vol. 1: Dioxin '90-EPRI Seminar, Toxicology, Environment, Food, Exposure-Risks (Eds. Hutzinger O and Fielder H), pp. 177-180. Ecoinforma Press, Bayreath, 1990.
30. 30. Hahn MA, Gasiewicz TA, Linko P and Goldstein, JA, The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice. Biochem J 254: 245-254, 1988.
31. 31. Francis JE and Smith AG, Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase. FEBS Lett 233: 311-314, 1988.
32. 32. De Matteis F, Harvey C, Reed C and Hempenius R, Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Possible relevance to drug-induced uroporphyna. Biochem J 250: 167-169, 1988.
33. 33. Monteiro HP, Abdalla DSP, Augusto O and Bechara EJH, Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinopathies. Arch Biochem Biophys 271: 206-216, 1989.
34. 34. Jacobs JM, Sinclair R, Bernent WJ, Lambrecht RW, Sinclair JF and Goldstein JA, Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P450. Essential role of cytochrome P-450d. Biochem J 258: 247-253, 1989.
35. 35. Sinclair PR, Gorman N, Sinclair JF, Walton HS, Bernent WJ and Larnbrecht RW, Ascorbic acid inhibits chemically induced uroporphyria in ascorbate requiring rats. Hepatology 22: 565-572, 1995.
36. 36. Hahn ME, Goldstein JA, Linko P and Gasiewicz TA, Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo and in vitro. Evidence that hexachlorobenzene is a weak Ah receptor agonist. Arch Biochem Biophys 270: 344-355, 1989.
37. 37. De Verneuil H, Sassa S and Kappas A, Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Biochem J 214: 145-151, 1983.
38. 38. Ferioli A, Harvey C and De Matteis F, Drug-induced accumulation of uroporphyrin in chicken hepatocyte cultures. Biochem J 224: 769-777, 1984.
39. d mice. Toxicologist 30: 181, 1996.